Dr. Reddy's Laboratories Share Price
Large Cap | Pharmaceuticals and health care | NSE: DRREDDY | BSE: 500124
₹1,109.95 -41.50 (-3.60 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 1,151.80
High (₹) 1,157.45
Low (₹) 1,076.20
Prev. Close (₹) 1,151.45
Volume 54,23,860
VWAP (₹) 1,117.38
ROCE (%) 25.13
Industry P/E 44.73
TTM P/E 17.24
P/B Ratio 0.66
Market Cap (₹) Cr.92,620.37
Dividend Yield (%)3.60
EPS (₹) 334.59
ROE19.75%
Sales Growth (%) 13.54
Profit Growth (%)24.45
Day Range
1,157.451,157.45
52 Week Range
1,076.401,420.20
Historical Returns
Returns (6M)
-16.04 %
Returns (1Y)
-10.19 %
Returns (3Y)
29.77 %
Returns (5Y)
54.88 %
Returns (6M)
-16.04 %
Returns (1Y)
-10.19 %
Returns (3Y)
29.77 %
Returns (5Y)
54.88 %
SWOT Analysis
- Company with (23.51%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 23.51% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
RSI 27.72
MFI 28.49
ATR 29.54
Commodity Channel Index -156.50
ROC125 -18.77
ROC21 -6.53
Williams %R -91.37
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 1,130.81 | 1,145.13 | 1,158.26 | 1,117.68 | 1,103.36 | 1,090.23 | 1,075.91 |
Week Ago | 1,166.61 | 1,181.43 | 1,192.11 | 1,155.93 | 1,141.11 | 1,130.43 | 1,115.61 |
Month Ago | 1,197.71 | 1,214.18 | 1,230.71 | 1,181.18 | 1,164.71 | 1,148.18 | 1,131.71 |
EMA & SMA
1109.95
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 1142.14
9 Day 1165.98
10 Day 1168.11
12 Day 1179.38
14 Day 1183.41
20 Day 1192.35
26 Day 1195.28
50 Day 1268.20
100 Day 1267.91
200 Day 1282.67
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 14 Nov, 2022 | ₹4,539.45 | 1,80,717 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 14 Nov, 2022 | ₹4,539.45 | 1,80,717 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Nov, 2022 | ₹4,555.65 | 1,80,718 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Nov, 2022 | ₹4,555.65 | 1,80,718 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹4,335.70 | 1,49,492 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹4,335.70 | 1,49,492 | NSE |
ISHARES INDIA MAURITIUS CO | block | Sell | 08 Aug, 2022 | ₹4,156.85 | 19,329 | NSE |
ISHARES INDIA INDEX MAURITIUS COMPANY | block | Sell | 08 Aug, 2022 | ₹4,156.85 | 1,37,595 | NSE |
ISHARES MSCI INDIA ETF | block | Buy | 08 Aug, 2022 | ₹4,156.85 | 1,37,595 | NSE |
ISHARES INDIA 50 ETF | block | Buy | 08 Aug, 2022 | ₹4,156.85 | 19,329 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
26 Sept, 2024 | Vincent Colicchio | Acquisition | ₹6,553.00 | 1,594 | NSE |
26 Sept, 2024 | Anjum Swaroop | Acquisition | ₹6,553.00 | 1,412 | NSE |
26 Sept, 2024 | C Swaminathan | Disposal | ₹6,651.41 | 1,700 | NSE |
04 Sept, 2024 | Bryan Dixon | Acquisition | ₹6,914.00 | 150 | NSE |
04 Sept, 2024 | Milan Kalawadia | Acquisition | ₹6,914.00 | 814 | NSE |
04 Sept, 2024 | Subba Inta | Acquisition | ₹6,914.00 | 704 | NSE |
04 Sept, 2024 | C Swaminathan | Acquisition | ₹6,914.72 | 1,250 | NSE |
04 Sept, 2024 | Juan Carlos Alvarez | Acquisition | ₹6,914.00 | 145 | NSE |
04 Sept, 2024 | Sanjay Choubey | Acquisition | ₹6,914.00 | 215 | NSE |
04 Sept, 2024 | Tricia Wetzel | Acquisition | ₹6,802.78 | 594 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
27 Jul, 2024 | Stock Split from Rs. 5/- to Re. 1/- | 28 Oct, 2024 | 28 Oct, 2024 |
07 May, 2024 | Rs.40.0000 per share(800%)Final Dividend | 16 Jul, 2024 | 01 Jan, 1970 |
10 May, 2023 | Rs.40.0000 per share(800%)Final Dividend | 11 Jul, 2023 | 01 Jan, 1970 |
19 May, 2022 | Rs.30.0000 per share(600%)Final Dividend | 11 Jul, 2022 | 01 Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
01 Apr, 2025 | BSE India | Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 |
01 Apr, 2025 | NSE India | Dr. Reddy''s Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
24 Mar, 2025 | NSE India | DR. REDDY''S LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window |
24 Mar, 2025 | NSE India | DR. REDDY''S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 09-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend. |
22 Mar, 2025 | NSE India | Dr. Reddy''s Laboratories Limited has informed the Exchange about General Updates |
21 Mar, 2025 | NSE India | Dr. Reddy''s Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
20 Mar, 2025 | NSE India | Dr. Reddy''s Laboratories Limited has informed the Exchange about Copy of Newspaper Publication |
13 Mar, 2025 | NSE India | Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2025, titled ""Press Release"". |
13 Mar, 2025 | BSE India | Press Release |
12 Mar, 2025 | NSE India | Dr. Reddy''s Laboratories Limited has informed the Exchange about Schedule of meet |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Audited Results, Dividend & Others | To consider other business matters. | 25 Mar, 2025 | 09 May, 2025 |
Quarterly Results | -- | 24 Dec, 2024 | 23 Jan, 2025 |
Quarterly Results | -- | 01 Oct, 2024 | 05 Nov, 2024 |
Quarterly Results & Stock Split | -- | 24 Jul, 2024 | 27 Jul, 2024 |
Audited Results & Final Dividend | -- | 26 Mar, 2024 | 07 May, 2024 |
Quarterly Results | -- | 22 Dec, 2023 | 30 Jan, 2024 |
Quarterly Results | -- | 26 Sept, 2023 | 27 Oct, 2023 |
Quarterly Results | -- | 11 Jul, 2023 | 26 Jul, 2023 |
Audited Results & Final Dividend | -- | 24 Mar, 2023 | 10 May, 2023 |
Quarterly Results | -- | 28 Dec, 2022 | 25 Jan, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 26.64% | 26.65% | 26.7% | 26.72% | 26.73% |
Foreign Institutions + | 26.85% | 28.62% | 27.29% | 27.42% | 29.13% |
Domestic Institutions + | 36.12% | 33.98% | 33.91% | 22.29% | 14.72% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 10.23% | 10.57% | 11.85% | 23.29% | 29.2% |
Others | 0.16% | 0.18% | 0.25% | 0.28% | 0.22% |
About Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 19483.80 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2024.
Parent Organisation
Reddy Group
Founded
1984
Managing Director
-- --
NSE Symbol
DRREDDY
Dr. Reddy's Laboratories Management
Name | Designation |
---|---|
Mr. K Satish Reddy | Chairman |
Mr. G V Prasad | Co-Chairman & Manag. Director |
Dr. Claudio Albrecht | Independent Director |
Ms. Kalpana Morparia | Independent Director |
Mr. Leo Puri | Independent Director |
Ms. Shikha Sharma | Independent Director |
Mr. Sanjiv Mehta | Independent Director |
Mr. Arun M Kumar | Independent Director |
Dr. K P Krishnan | Independent Director |
Ms. Penny Wan | Independent Director |
Dr. Alpna Seth | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Dr. Reddy's Laboratories
What is the share price of Dr. Reddy's Laboratories?
The share price of Dr. Reddy's Laboratories on 04 Apr, 2025 is ₹ 1,109.95.
What is 52W high and 52W low share price of Dr. Reddy's Laboratories?
The highest and lowest 52W share prices of Dr. Reddy's Laboratories are ₹ 1420.200 and ₹ 1093.000
What is the market cap of Dr. Reddy's Laboratories?
The market capitalization of Dr. Reddy's Laboratories as of 04 Apr, 2025 is ₹ 92,620.37 Crores
What is the P/E ratio of Dr. Reddy's Laboratories?
The current P/E ratio of Dr. Reddy's Laboratories as of 04 Apr, 2025 is 44.73
What is the PB ratio of Dr. Reddy's Laboratories?
The PB ratio of Dr. Reddy's Laboratories as of 04 Apr, 2025 is 0.66
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)